Diana Harshbarger

02/03/2026 | Press release | Archived content

Harshbarger Issues Statement Following Vote to Advance FY 2026 Appropriations

WASHINGTON, D.C. - Congresswoman Diana Harshbarger today voted in support of the Fiscal Year 2026 Consolidated Appropriations Act, helping send the bill to President Trump's desk for his signature. Following the vote, Harshbarger issued the following statement:

"This legislation restores fiscal responsibility to the appropriations process while delivering real reforms that lower costs for patients and families," said Congresswoman Diana Harshbarger. "This package makes critical investments in our national defense, fully supports our troops, strengthens public safety, and includes meaningful PBM reforms to rein in abusive practices that drive up drug prices. It avoids a bloated omnibus, cuts wasteful spending, and advances an America First agenda that puts patients, taxpayers, and national security first. I'm proud to support responsible governance and to help move this bill to President Trump's desk."

Following the vote, President Trump signed this funding package into law.

Background:

The FY 2026 funding package includes significant pharmacy benefit manager reforms championed by Congresswoman Harshbarger, a pharmacist and longtime leader in Congress on lowering prescription drug costs. Harshbarger has helped lead the charge to expose PBM abuses, introduce bipartisan reforms, and push these policies through the legislative process to protect independent pharmacies and ensure patients-not middlemen-come first.

The legislation also includes provisions based on Congresswoman Harshbarger's bipartisan United States-Abraham Accords Cooperation and Security Act , legislation she introduced to strengthen U.S. healthcare supply chains by deepening cooperation with trusted allies. These provisions support the establishment of a technical office within the Food and Drug Administration to help reduce America's reliance on medical products manufactured in adversarial nations like China, while bolstering innovation, security, and resilience across the healthcare system.

Diana Harshbarger published this content on February 03, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 05, 2026 at 16:55 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]